Clinical trial
SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe AECB
NCT00879008 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe AECB
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2009
- Completion date
- August 31, 2010
- Enrollment
- 345 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic bronchitis